{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:35:24Z","timestamp":1770489324044,"version":"3.49.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,1,20]],"date-time":"2018-01-20T00:00:00Z","timestamp":1516406400000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bannwarth syndrome (BWS), an infrequent manifestation of neuroinvasive Lyme disease (LD) characterized by radiculopathy, neuropathy, and lymphocytic pleocytosis, is more commonly documented in Europe than North America. Here, we describe a cluster of 5 neuroinvasive LD cases with BWS in the upper Midwest United States between July and August 2017.<\/jats:p>","DOI":"10.1093\/ofid\/ofx276","type":"journal-article","created":{"date-parts":[[2017,12,24]],"date-time":"2017-12-24T10:48:53Z","timestamp":1514112533000},"source":"Crossref","is-referenced-by-count":21,"title":["An Unusual Cluster of Neuroinvasive Lyme Disease Cases Presenting With Bannwarth Syndrome in the Midwest United States"],"prefix":"10.1093","volume":"5","author":[{"given":"Aditya","family":"Shah","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C","family":"O\u2019Horo","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota"},{"name":"Division of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W","family":"Wilson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dane","family":"Granger","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elitza S","family":"Theel","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,12,23]]},"reference":[{"key":"2020081004170779100_CIT0001","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cll.2010.01.003","article-title":"Lyme disease","volume":"30","author":"Murray","year":"2010","journal-title":"Clin Lab Med"},{"key":"2020081004170779100_CIT0002","first-page":"590","article-title":"Notice to readers: recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease","volume":"44","author":"CDC","year":"1995","journal-title":"MMWR"},{"key":"2020081004170779100_CIT0003","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","article-title":"Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain","volume":"37","author":"Reiber","year":"1991","journal-title":"Clin Chem"},{"key":"2020081004170779100_CIT0004","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.diagmicrobio.2008.08.016","article-title":"Percent positive rate of Lyme real-time polymerase chain reaction in blood, cerebrospinal fluid, synovial fluid, and tissue","volume":"62","author":"Babady","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020081004170779100_CIT0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"2020081004170779100_CIT0006","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020081004170779100_CIT0007","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020081004170779100_CIT0008","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cll.2015.07.002","article-title":"Nervous system Lyme disease","volume":"35","author":"Halperin","year":"2015","journal-title":"Clin Lab Med"},{"key":"2020081004170779100_CIT0009","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciw299","article-title":"Course and outcome of early European lyme neuroborreliosis (Bannwarth Syndrome): clinical and laboratory findings","volume":"63","author":"Ogrinc","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020081004170779100_CIT0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3174\/ajnr.A1579","article-title":"Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis","volume":"30","author":"Hildenbrand","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"2020081004170779100_CIT0011","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"2020081004170779100_CIT0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14737159.2016.1246959","article-title":"Progress in the molecular diagnosis of Lyme disease","volume":"17","author":"Ru\u017ei\u0107-Sablji\u0107","year":"2017","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/1\/ofx276\/33577234\/ofx276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/1\/ofx276\/33577234\/ofx276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T08:22:11Z","timestamp":1597047731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofx276\/4773955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,23]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofx276","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,12,23]]},"article-number":"ofx276"}}